External reference pricing
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
External reference pricing (ERP), also known as international reference pricing, is the practice of regulating the price of a medication in one country, by comparing with the price in a "basket" of other reference countries. It contrasts with internal reference pricing, where the price of one drug is compared to the domestic price of therapeutically related drugs, and with cost-plus pricing, where the price involves negotiating an acceptable markup to the unit cost to develop and produce.
External reference pricing (ERP), also known as international reference pricing, is the practice of regulating the price of a medication in one country, by comparing with the price in a "basket" of other reference countries. It contrasts with internal reference pricing, where the price of one drug is compared to the domestic price of therapeutically related drugs, and with cost-plus pricing, where the price involves negotiating an acceptable markup to the unit cost to develop and produce.
References
External links
HAI list of multi-country price sources, with scope and supply chain price component information. HAI list of national price sources, with scope and supply chain price component information. HAI medicine prices, availability, affordability and price components database WHO list of price data sources globally, with scope and update frequency. Common European Drug Database , maintained by the National Health Insurance Fund Administration of Hungary.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1337363716 under CC BY-SA 4.0; modifications have been made.